Home Cancer

Keyword: Cancer

82 results found
Copyright_radachynskyi_123RF

Two-thirds (68 per cent) of global employers with high levels of employee engagement say they have a well defined diversity, equity and inclusion plan, according to a new survey by Aon. The survey, which polled more than 1,200 benefits and DEI leaders in 55 countries, found while three-quarters (74 per cent) of employers have an […]

  • By: Staff
  • November 23, 2022 November 24, 2022
  • 15:00

Employer-sponsored health benefits cost trends are expected to increase by a record 10 per cent on average globally in 2023, amid rising inflation and increasing health-care utilization, according to a new survey by WTW. The survey, which polled more than 250 insurers representing 55 countries, found cost trends in Canada are expected to increase by […]

  • By: Staff
  • October 17, 2022 October 17, 2022
  • 15:00

Nearly three-quarters (73 per cent) of employers have increased their communications emphasis on mental-health and behavioural health offerings in the past two years, according to a new survey by the International Foundation of Employee Benefit Plans. In addition, the survey found 90 per cent of employers said they offer employee assistance programs, 86 per cent […]

  • By: Staff
  • July 27, 2022 July 27, 2022
  • 09:00

As the coronavirus pandemic continues, fewer Canadian benefits plan members are making drug claims, according to Telus Health’s annual drug trends report. The report, based on the drug claims activity of more than 10 million plan members in 2021, found just 56 per cent made a claim in 2021, reflecting a decreased frequency of in-person […]

  • By: Staff
  • June 23, 2022 June 22, 2022
  • 09:00

While medications used for treating inflammatory disease accounted for just 0.7 per cent of claims across Telus Health’s Canadian block of business in 2021, they represent the largest percentage of eligible drug costs at 12.6 per cent, due to the prevalence of high-cost treatments in this drug class. By comparison, diabetes medications accounted for 12 […]

In Canada, the year-over-year cost increase for claims under a medical plan on a per-person basis is projected to reach 8.6 per cent this year, up from eight per cent in 2021, according to a new report by Mercer Canada. The report, which analyzed responses from 210 insurers across 59 countries, found the year-over-year cost […]

  • By: Staff
  • March 30, 2022 March 29, 2022
  • 09:00

Employer-sponsored health benefits cost trends are expected to increase 8.1 per cent on average globally in 2022, according to a new survey by Willis Towers Watson. The survey, which polled medical insurers across various geographic regions, found cost trends are expected to be as high as 14.2 per cent in Latin America, followed by 10.6 […]

  • By: Staff
  • November 19, 2021 November 19, 2021
  • 15:00
Editorial

With the Delta variant leading the coronavirus pandemic in a renewed surge, employers continue to have a surplus of challenges, regardless of whether or not they’re planning a return to the workplace. I discussed this latter challenge in my Editorial last month, but at the risk of heaping on more doom and gloom, it may […]

As innovative medicines become more widely covered in workplace drug plans, employers are tasked with finding new ways to control costs while ensuring members receive the best value. “Obviously, this is good because such offers provide more treatments for employees and their families that can help get them back to the workplace sooner rather than […]

While the rates of drug and disability claims are returning to their pre-pandemic levels, employers are still contending with the impact of the coronavirus crisis on their benefits plans. Following the declaration of the pandemic in March 2020, there was a subsequent surge in drug claims attributed to medication stockpiling, said Frédéric Leblanc, strategic advisor […]